Table 2 Characteristics of patients with and without NAFLD after 1:1 case–control matching

 Male

331 (56.3%)

331 (56.3%)

 Female

257 (43.7%)

257 (43.7%)

Age (years)

60.12 ± 9.18

60.08 ± 9.11

0.93

Diabetes duration (years)

10.25 ± 5.36

10.14 ± 5.33

0.74

 Male

93.45 ± 6.51

93.71 ± 6.50

0.61.

 Female

89.79 ± 7.48

89.87 ± 7.35

0.90

HbA1c (%)

8.11 ± 1.56

8.13 ± 1.46

0.76

ALT (IU/L)

21.61 ± 34.60

26.12 ± 16.68

0.005

AST (IU/L)

19.65 ± 18.70

21.46 ± 9.19

0.035

Gamma-GT (IU/L)

30.11 ± 34.75

36.30 ± 28.91

0.001

TC (mmol/L)

4.60 ± 1.01

4.68 ± 1.10

0.228

TG (mmol/L)

1.39 ± 0.82

2.07 ± 1.34

< 0.001

LDL-C (mmol/L)

2.81 ± 0.84

2.75 ± 0.89

0.307

Gallstone disease

139 (23.6%)

150 (25.5%)

0.15

Cholecystectomy

66 (11.2%)

102 (17.3%)

< 0.001

Gallstones

73 (12.4%)

48 (8.1%)

< 0.001